<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diamond-Blackfan <z:hpo ids='HP_0001903'>anemia</z:hpo> (<z:chebi fb="28" ids="35299">DBA</z:chebi>) is a congenital <z:hpo ids='HP_0012133'>erythroid hypoplasia</z:hpo> caused by a functional haploinsufficiency of genes encoding for ribosomal proteins </plain></SENT>
<SENT sid="1" pm="."><plain>Among these genes, ribosomal protein S19 (RPS19) is mutated most frequently </plain></SENT>
<SENT sid="2" pm="."><plain>Generation of animal models for diseases like <z:chebi fb="28" ids="35299">DBA</z:chebi> is challenging because the phenotype is highly dependent on the level of RPS19 down-regulation </plain></SENT>
<SENT sid="3" pm="."><plain>We report the generation of mouse models for RPS19-deficient <z:chebi fb="28" ids="35299">DBA</z:chebi> using transgenic <z:chebi fb="40" ids="33697">RNA</z:chebi> interference that allows an inducible and graded down-regulation of Rps19 </plain></SENT>
<SENT sid="4" pm="."><plain>Rps19-deficient mice develop a <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> together with <z:mp ids='MP_0000221'>leukocytopenia</z:mp> and variable platelet count that with time leads to the exhaustion of hematopoietic stem cells and <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Both RPS19 gene transfer and the loss of p53 rescue the <z:chebi fb="28" ids="35299">DBA</z:chebi> phenotype implying the potential of the models for testing novel therapies </plain></SENT>
<SENT sid="6" pm="."><plain>This study demonstrates the feasibility of transgenic <z:chebi fb="40" ids="33697">RNA</z:chebi> interference to generate mouse models for human diseases caused by haploinsufficient expression of a gene </plain></SENT>
</text></document>